α/β-Hydrolase-IN-1 exhibits best-in-class minimum inhibitory concentration (MIC) values of 50 μM (25 μg/mL) against M. smegmatis and 16 μM (8.4 μg/mL) against M. tuberculosis H37Ra, indicating its application as an antimicrobial agent targeting mycobacteria.